Risk of hepatitis B reactivation in patients receiving anti‐tumor necrosis factor‐α therapy

Objective The purpose of this study was to determine hepatitis B virus (HBV) screening rates in patients receiving anti‐tumor necrosis factor (TNF)‐α therapy and the frequency of HBV reactivation in patients with resolved hepatitis B virus infection (hepatitis B surface antigen [HBsAg] negative, hep...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of rheumatic diseases 2021-02, Vol.24 (2), p.254-259
Hauptverfasser:	Fidan, Sami, Capkın, Erhan, Arıca, Deniz Aksu, Durak, Serdar, Okatan, Ilyas Ercan
Format:	Artikel
Sprache:	eng
Schlagworte:	antirheumatic therapy anti‐tumor necrosis factor therapy Deoxyribonucleic acid DNA Gastroenterology Hepatitis B Hepatitis B surface antigen hepatitis B virus reactivation hepatitis B virus screening Necrosis Prophylaxis Seroconversion Tumor necrosis factor Tumor necrosis factor-TNF
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!